Does Insulin Human Interact with Levothyroxine Sodium Anhydrous?
Insulin Human and Levothyroxine Sodium Anhydrous have a moderate drug interaction according to U.S. FDA drug labeling data. Addition of levothyroxine to insulin therapy may result in increased insulin requirements. Careful monitoring of diabetic control is recommended. The mechanism involves levothyroxine alters metabolism and pharmacokinetics of insulin. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Moderate
- Insulin Human Class
- Insulin
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
How This Interaction Works
The interaction between Insulin Human and Levothyroxine Sodium Anhydrous occurs because levothyroxine alters metabolism and pharmacokinetics of insulin. Clinically, this means addition of levothyroxine to insulin therapy may result in increased insulin requirements. careful monitoring of diabetic control is recommended. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.
What To Tell Your Doctor or Pharmacist
If you are taking Insulin Human and your doctor is considering prescribing Levothyroxine Sodium Anhydrous (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider